Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017

BACKGROUND: It is estimated that up to a third of patients on opioid agonist therapy (OAT) have attention deficit hyperactivity disorder (ADHD). Treatment by ADHD medication, including a centrally acting stimulant (CAS) or atomoxetine is one of the essential approaches. This study evaluates the use...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Psychiatry
Main Authors: Vold, Jørn Henrik, Aas, Christer, Skurtveit, Svetlana, Odsbu, Ingvild, Chalabianloo, Fatemeh, Halmøy, Anne, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068965/
https://ncbi.nlm.nih.gov/pubmed/32164615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-020-02526-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados